Cisatracurium Dosing Requirements in COVID-19 Compared to Non-COVID-19 Patients

J Pharm Pract. 2023 Jun;36(3):485-486. doi: 10.1177/08971900211052835. Epub 2021 Oct 21.

Authors

Megan Ingebrigtson¹, Nicholas Farina¹, James Miller¹, Karl Renius¹, Jakob I McSparron², Michael Kenes³

Affiliations

¹ Department of Pharmacy Services, Michigan Medicine, Ann Arbor, MI, USA.
² Department of Pulmonary and Critical Care Medicine, Michigan Medicine, Ann Arbor, MI, USA.
³ Department of Clinical Pharmacy, College of Pharmacy, University of Michigan, Ann Arbor, MI, USA.

No abstract available

Publication types

Editorial

MeSH terms

Atracurium
COVID-19*
Humans
Infusions, Intravenous

Substances

cisatracurium
Atracurium